IGF2BP2 and colorectal cancer: In concert with IGF2BP2, METTL3 promotes m6A modification of the SOX2 CDS region to inhibit SOX2 RNA degradation, which increases the protein content of intracellular SOX2 and induces colorectal cancer metastasis [69].